Family medicine physician Alex McDonald, MD, shares the reality of the pandemic on social media.
The senior investigator with the Kaiser Permanente Washington Health Research Institute discusses promising developments from clinical trials on a COVID-19 vaccine under development by Moderna and the National Institutes of Health.
The late-stage clinical trial will test the vaccine in 1,400 adults at 4 sites in California and Oregon.
A study published in the New England Journal of Medicine, led by Lisa A. Jackson, MD, of Kaiser Permanente’s Washington Health Research Institute, reports on promising results in the phase 1 trial of an experimental COVID-19 vaccine.
On a recent episode of NPR’s Weekend Edition Saturday, Lisa A. Jackson, MD, an internist with Washington Permanente Medical Group, shared her insights on the race among scientists to develop a vaccine for the new coronavirus that leads to COVID-19 disease.